Robyn C. Davis Joins Psychemedics Board of Directors
Psychemedics Corporation (NASDAQ: PMD) has appointed Robyn C. Davis to its Board of Directors, following the passing of Clint Allen.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Psychemedics Corporation (NASDAQ: PMD) has appointed Robyn C. Davis to its Board of Directors, following the passing of Clint Allen. Ms. Davis brings extensive experience in life sciences and strategy, having served on the boards of prominent companies like Brooks Automation and Akston Bioscience. She is a Managing Director at Angel Healthcare Investors and has advised various organizations on growth strategies. The company is a leader in drug testing, utilizing its patented hair testing method preferred by many Fortune 500 companies.
Positive
- Robyn C. Davis is expected to bring valuable experience in life sciences and corporate strategy to Psychemedics.
- Her appointment fills a key vacancy on the board and may enhance governance and strategic decision-making.
Negative
- The board vacancy followed the untimely passing of a long-time member, raising concerns about continuity and experience within the board.
Details
News Market Reaction – PMD
The recorded move for PMD in the trading session of this news was +0.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporation effective immediately. Ms. Davis will be filling the vacancy created by the untimely passing this past December of Clint Allen, a long- time and dedicated Psychemedics board member.
Ray Kubacki, Chairman and CEO stated “We are excited to have Robyn join our board. She brings a wealth of experience and a balanced perspective in a number of areas particularly in life sciences and strategy that will prove most helpful to Psychemedics growth as we move forward.”
Ms. Davis currently serves as a corporate Director for Brooks Automation (BRKS), a
Ms, Davis is also a Managing Director of Angel Healthcare Investors where she has managed early-stage investments in medical devices, life sciences, information technology and professional services over the past 20 years.
Throughout her career, Ms. Davis has advised governments, boards, CEO’s, and senior executives on value-creation, growth strategy, cost reduction, and leadership development. She has worked as an independent advisor as well as a Consultant at Bain & Co. and a Director at Barents, LLC.
Ms. Davis holds an Executive Masters Professional Director Certification from the American College of Corporate Directors and was also recognized by Women, Inc. magazine as a “Most Influential Corporate Director” in 2019. She is a graduate of Tufts University and Harvard Business School.
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over
Contact: Raymond C. Kubacki, Chairman, President and CEO
Phone: (978) 206-8220
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.